Obesity and prostate cancer detection: Insights from three national surveys

American Journal of Medicine

Volumn 123, Issue 9, 2010, Pages 829-835

  Parekh, Niyati ^a   Lin, Yong ^b,c   Dipaola, Robert S ^b,d   Marcella, Stephen ^b   Lu Yao, Grace ^b,c,d  

^a NEW YORK UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d Dean and Betty Gallo Prostate Cancer Center   (United States)

Author keywords

Biopsy; Detection; Obesity; Prostate cancer; Prostate specific antigen; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; HEALTH SURVEY; HUMAN; INTROSPECTION; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BIOPSY; BODY MASS INDEX; DISEASE PROGRESSION; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 77956200385     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.05.011     Document Type: Article

References (36)

1. C.L. Ogden, M.D. Carroll, and L.R. Curtin Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 2006 1549 1555
2. C.L. Amling, C.J. Kane, and R.H. Riffenburgh Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy Urology 58 2001 723 728
3. S.J. Freedland, W.J. Aronson, and C.J. Kane Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group J Clin Oncol 22 2004 446 453
4. E. Giovannucci, Y. Liu, and E.A. Platz Risk factors for prostate cancer incidence and progression in the health professionals follow-up study Int J Cancer 121 2007 1571 1578
5. M.E. Wright, S.C. Chang, and A. Schatzkin Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality Cancer 109 2007 675 684
6. C. Rodriguez, A.V. Patel, and E.E. Calle Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States Cancer Epidemiol Biomarkers Prev 10 2001 345 353
7. R.L. O'Malley, and S.S. Taneja Obesity and prostate cancer Can J Urol 13 Suppl 2 2006 11 17
8. Y. Furuya, S. Akimoto, K. Akakura, and H. Ito Smoking and obesity in relation to the etiology and disease progression of prostate cancer in Japan Int J Urol 5 1998 134 137
9. E. Giovannucci, E.B. Rimm, and M.J. Stampfer Height, body weight, and risk of prostate cancer Cancer Epidemiol Biomarkers Prev 6 1997 557 563
10. S.F. Shariat, P.T. Scardino, and H. Lilja Screening for prostate cancer: an update Can J Urol 15 2008 4363 4374
11. I.M. Thompson, D.K. Pauler, and P.J. Goodman Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter N Engl J Med 350 2004 2239 2246
12. J.A. Efstathiou, M.H. Chen, and W.J. Catalona Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality Urology 68 2006 342 347
13. A. Rundle, C. Richards, and A.I. Neugut Hemodilution of prostate-specific antigen levels among obese men Cancer Epidemiol Biomarkers Prev 18 2009 2343 author reply 2343-2344
14. T.M. Ezzati, J.T. Massey, and J. Waksberg Sample design: Third National Health and Nutrition Examination Survey Vital Health Stat 2 1992 1 35
15. E.W. Gunter, B.G. Lewis, and S.M. Koncikowski Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 1996 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Hyattsville, MD
16. Third National Health and Examination Survey 1988-1994 documentation, codebook and frequencies Inhibin B, Luteinizing hormone, Testosterone http://www.cdc.gov/nchs/data/nhanes/nh3data/htm Accessed April 30, 2010
17. The World Health Organization Report http://www.who.int/whr/2002/ chapter4/en/index4.html Accessed April 30, 2010
18. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics National Health and Nutrition Examination Survey (NHANES): Questionnaires, Examination Components, and Laboratory Components, 2003-2004 http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/questexam03-04.htm Accessed April 30, 2010
19. The National Health and Examination Survey 2003-2004 documentation on MEC Laboratory Component: Prostate Specific Antigen (PSA) http://www.cdc.gov/nchs/ data/nhanes/nhanes-03-04/l11psa-c.pdf Accessed April 30, 2010
20. D.M. Werny, T. Thompson, and M. Saraiya Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004 Cancer Epidemiol Biomarkers Prev 16 2007 70 76
21. Division of Health Interview Statistics, National Center for Health Statistics 2000 National Health Interview Survey (NHIS) Public Use Data Release: NHIS Survey Description 2002 National Center for Health Statistics Hyattsville, MD
22. A. Agresti Categorical Data Analysis 2nd edition 2002 Wiley Hoboken, NJ
23. J.A. Osuna, R. Gomez-Perez, G. Arata-Bellabarba, and V. Villaroel Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men Arch Androl 52 2006 355 361
24. B.A. Mohr, S. Bhasin, and C.L. Link The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study Eur J Endocrinol 155 2006 443 452
25. S.M. Gapstur, P. Kopp, and P.H. Gann Changes in BMI modulate age-associated changes in sex hormone binding globulin and total testosterone, but not bioavailable testosterone in young adult men: the CARDIA Male Hormone Study Int J Obes (Lond) 31 2007 685 691
26. S. Culp, and M. Porter The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men BJU Int 104 2009 1457 1461
27. G. Lu-Yao, P.C. Albertsen, and J.L. Stanford Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut BMJ 325 7367 2002 740
28. E. Giovannucci, E.B. Rimm, and Y. Liu Body mass index and risk of prostate cancer in U.S. health professionals J Natl Cancer Inst 95 2003 1240 1244
29. R.J. MacInnis, D.R. English, and D.M. Gertig Body size and composition and prostate cancer risk Cancer Epidemiol Biomarkers Prev 12 2003 1417 1421
30. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
31. S.O. Andersson, A. Wolk, and R. Bergstrom Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers J Natl Cancer Inst 89 1997 385 389
32. M.D. Fesinmeyer, R. Gulati, and S. Zeliadt Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States Cancer Epidemiol Biomarkers Prev 18 2009 808 815
33. S.J. Freedland, E.A. Platz, and J.C. Presti Jr Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection J Urol 175 2006 500 504
34. S.J. Freedland, and E.A. Platz Obesity and prostate cancer: making sense out of apparently conflicting data Epidemiol Rev 29 2007 88 97
35. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
36. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534